Get the app!
Back to Trades

Davidson Matt

President and CEODirectorCIK 0001741937

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Davidson Matt, President and CEO, Director, has filed 4 SEC reports (2026), all concentrated in Azora Therapeutics, Inc. (DE) (AZR), totaling $1.1M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Nov 4AZR
Azora Therapeutics, Inc. (DE)
Davidson MattPresident and CEO, DirectorConversion$0
Oct 30ADIL
ADIAL PHARMACEUTICALS, INC.
Davidson MattPresident and CEO, DirectorGrant$414.9K
Jun 16ADIL
ADIAL PHARMACEUTICALS, INC.
Davidson MattChief Development Officer, DirectorGrant$671.7K
Jun 16ADIL
ADIAL PHARMACEUTICALS, INC.
Davidson MattChief Development Officer, DirectorOther$0

4 filings